Table 2 Changes in plasma lipids and CRP from baseline in the total population at 6 months.

From: A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being

Outcome

Group

Difference (95% CI)

% change

p value

TC (mmol/L)

Between

0.016 (−0.15, 0.18)

0.29

0.8480

Active

−0.009 (−0.12, 0.11)

−0.17

0.8809

Placebo

−0.025 (−0.14, 0.09)

−0.46

0.6738

HDL-C (mmol/L)

Between

−0.014 (−0.70, 0.04)

−0.99

0.6350

Active

0.005 (−0.03, 0.04)

0.36

0.8094

Placebo

0.018 (−0.02, 0.06)

1.35

0.3614

LDL-C (mmol/L)

Between

−0.002 (−0.13, 0.13)

0.00

0.9806

Active

0.087 (−0.01, 0.18)

2.70

0.0667

Placebo

0.088 (0.00, 0.18)

2.70

0.0618

TG (mmol/L)

Between

0.153 (−0.10, 0.41)

8.69

0.2393

Active

0.020 (−0.16, 0.20)

1.36

0.8326

Placebo

−0.132 (−0.31, 0.05)

−7.33

0.1480

CRP (mg/L)

Between

−0.283 (−1.37, 0.81)

−7.35

0.6092

Active

−0.199 (−0.97, 0.57)

−4.67

0.6100

Placebo

0.084 (−0.68, 0.85)

2.68

0.8302

  1. Data is presented as mean change (110 participants per group) with 95% CIs and p values calculated using a GLM. CI, confidence interval; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol, TG, triglycerides; CRP, C-reactive protein.
Back to article page